Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia

Published:2009-06 Issue:6 Volume:37 Page:679-691
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Barbarroja Nuria,Torres Luis Arístides,Luque Maria Jose,Carretero Rosario Maria,Valverde-Estepa Araceli,Lopez-Sanchez Laura Maria,Rodriguez-Ariza Antonio,Velasco Francisco,Torres Antonio,López-Pedrera Chary

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A heterozygousCEBPAmutation disrupting the bZIP domain causes MDS disease progression;2023-07-26

2. In-silico probing of AML related RUNX1 cancer-associated missense mutations: Predicted relationships to DNA binding and drug interactions;Frontiers in Molecular Biosciences;2022-08-25

3. Anti‐VEGF DNA‐based aptamers in cancer therapeutics and diagnostics;Medicinal Research Reviews;2020-10-10

4. CS2164 suppresses acute myeloid leukemia cell growth via inhibiting VEGFR2 signaling in preclinical models;European Journal of Pharmacology;2019-06

5. Targeting the Bone Marrow Niche in Hematological Malignancies;Hematopoietic Stem Cell Niche;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP